Atlas Trials

Melatonin in Alzheimer's Disease: Effect on Disease Progression and Epileptiform Activity.

Clinical trial NCT04522960 · UNKNOWN

Trial details

NCT number
NCT04522960
Sponsor
Universitair Ziekenhuis Brussel
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2020-10-20
Primary completion
2023-07-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.